Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diquafosol in Dry Eye Disease (Age Comparison)
NCT06560580Completed
- Sponsor
- Tianjin Eye Hospital
- Start
- Nov 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of diquafosol in dry eye disease (DED) (2 arms), sponsored by Tianjin Eye Hospital. Primary endpoints: Dry Eye Questionnaire at 3 months, Visual Acuity at 3 months and 5 more. Started Nov 2021; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06560580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06560580.